Ancora Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Ancora Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.68K	Hold	54	–	–	﹤0.01%	1990
2025 Q4	$4.58K	Hold	54	–	–	﹤0.01%	1980
2025 Q3	$3.92K	Buy	+54	New	+$3.73K	﹤0.01%	1542
2023 Q4	–	Sell	-111	Closed	-$6.55K	–	1793
2023 Q3	$6.55K	Hold	111	–	–	﹤0.01%	1357
2023 Q2	$6.63K	Hold	111	–	–	﹤0.01%	1340
2023 Q1	$6.49K	Hold	111	–	–	﹤0.01%	1360
2022 Q4	$7K	Hold	111	–	–	﹤0.01%	1416
2022 Q3	$6K	Hold	111	–	–	﹤0.01%	1602
2022 Q2	$7K	Buy	+111	New	+$7.05K	﹤0.01%	1688

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Ancora Advisors's IHE Position: Q1 2026 in Review

Ancora Advisors held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 54 shares worth $4.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

Ancora Advisors first reported a position in IHE in Q2 2022 and has held it in 9 quarters since. The position peaked at $7K in Q4 2022. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

Ancora Advisors held 54 shares of iShares US Pharmaceuticals ETF worth $4.68K as of Q1 2026.
Ancora Advisors left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1990 holding.
Ancora Advisors first reported a position in iShares US Pharmaceuticals ETF in Q2 2022 and has held it in 9 quarters since.
Ancora Advisors's iShares US Pharmaceuticals ETF position peaked at $7K in Q4 2022.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.